Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Lilly claims structurally novel NK1 antagonists

Nov. 25, 1996

NeoTherapeutics' lead small molecule advances toward clinical trials in AD

Nov. 22, 1996

Guilford's orally active neuroimmunophilin highly effective in animal models of Parkinson's disease

Nov. 22, 1996

Lamotrigine now available in France

Nov. 22, 1996

Antiparkinsonian skin patch enters pivotal phase II trial

Nov. 22, 1996

Approval recommended for Elan's gel formulation of diazepam

Nov. 21, 1996

SIBIA Neurosciences reports preclinical results with NAChR-selective compounds

Nov. 21, 1996

NIH to conduct clinical trial of Ampalex in AD

Nov. 21, 1996

First pivotal trial for panic disorder Rx

Nov. 20, 1996

Cephalon/Leo neurological disease collaboration

Nov. 20, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...